TITLE

Intravenous immunoglobulin therapy for asthma: time for a closer look?

AUTHOR(S)
Corrigan, C. J.
PUB. DATE
July 1997
SOURCE
Thorax;Jul1997, Vol. 52 Issue 7, p593
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66299131

 

Related Articles

  • Immunotherapy.  // CMAJ: Canadian Medical Association Journal;9/13/2005 Supplement, Vol. 173, pS46 

    The article examines the use of injection immunotherapy in treating allergic asthma. Immune modulation has been found to modify the underlying disease processes of asthma. Subcutaneous allergen, anti-Immunoglobulin E therapy, and intravenous immunoglobulin were among the immunotherapeutic...

  • Other drugs for severe asthma and unconventional therapies.  // CMAJ: Canadian Medical Association Journal;11/30/99 Supplement, Vol. 161, pS39 

    The article focuses on the recommendations for the administration of drugs for asthma. The article offers guidelines for the dosage of asthma drugs including oral glucocorticosteroids, Methotrexate, Cyclosporine A, gold salts and intravenous immunoglobulin. The side effects of the drugs as well...

  • Adverse effects of intravenous immunoglobulin therapy. Ryan, Michael E.; Webster, Michael L.; al, et // Clinical Pediatrics;Jan1996, Vol. 35 Issue 1, p23 

    Looks at the adverse effects of intravenous immunoglobulin therapy. Phenomena in the central nervous, renal and pulmonary systems; Immune-mediated hemolysis; Immunologic complications.

  • Can magnesium ease asthma? R.M.D. // Cortlandt Forum;9/25/96, Vol. 9 Issue 9, p121 

    Reports on the favorable results of using intravenous bolus of magnesium sulfate in asthma therapy.

  • Prospective Study on CVID Patients with Adverse Reactions to Intravenous or Subcutaneous IgG Administration. Isabella Quinti; Annarosa Soresina; Carlo Agostini; Giuseppe Spadaro; Andrea Matucci; Ifigeneia Sfika; Helene Martini; Federica Borghese; Andrea Guerra; Vultaggio Alessandra; Marcella Visentini; Alessandro Plebani; Massimo Fiorilli // Journal of Clinical Immunology;May2008, Vol. 28 Issue 3, p263 

    Abstract Introduction  The multicenter prospective study provides information on adverse reactions to intravenous and subcutaneous immunoglobulin treatment in a cohort of 262 patients with common variable immunodeficiency. Severe adverse reactions are a rare but unpredictable event that...

  • Review: Omalizumab reduces asthma exacerbations and daily steroid use.  // ACP Journal Club;Jan/Feb2004, Vol. 140 Issue 1, p13 

    This article focuses on a study regarding anti-immunoglobulin E for chronic asthma, published in the 2003 issue of the journal "Cochrane Database of Systematic Reviews." For this study the researchers selected studies if they were randomized controlled trials comparing anti-immunoglobulin E at...

  • New approaches to the treatment of asthma. Busse, William W. // Discover;Mar1999, Vol. 20 Issue 3, pS-25 

    Explores approaches to treating asthma. Limitations of anti-inflammatory therapy; Control of immunoglobulin E; Regulation of cellular inflammation; Locating the asthma gene.

  • Vasculitis: Key Issues for the Clinician in Three Unique Diseases. Vinall, Maria // MD Conference Express;Dec2011, p20 

    The article discusses a study which highlights the possible treatment for churg-strauss syndrome (CSS) in the U.S. It states that CSS is a rare systemic vasculitis that is linked with asthma, eosinophilia, sinusitis, neuropathy and pulmonary infiltrates and could also be developed in patients...

  • Arthritis in Kawasaki disease after responding to intravenous immunoglobulin treatment. Kyung-Yil Lee; Jin-Hee Oh; Ji-Whan Han; Joon-Sung Lee; Byung-Churl Lee // European Journal of Pediatrics;Jul2005, Vol. 164 Issue 7, p451 

    Examines children who presented with arthritis after defervescence on intravenous immunoglobulin treatment. Brief information on Kawasaki disease (KD); Effectiveness of intravenous immunoglobulin therapy in KD; Information on arthritis after infection with Streptococcus.

  • CLINICAL EXPERIENCE WITH INTRAVENOUS IMMUNOGLOBULIN AND TNF-A INHIBITOR THERAPIES FOR RECURRENT PREGNANCY LOSS. Sills, Eric Scott; Walsh, David J.; Shkrobot, Lyuda V.; Palermo, Gianpiero D.; Walsh, Anthony P. H. // Ulster Medical Journal;2009, Vol. 78 Issue 1, p57 

    A letter to the editor is presented describing a clinical experience with intravenous immunoglobulin and TNF-A inhibitor therapies for recurrent pregnancy loss.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics